BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo

Ross R, Corinaldesi C, Migneco G, El-Sherbiny Y, Holmes S, Distler J, Mckimmie C, Del Galdo F (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

University of Leeds GB United Kingdom (GB) University of Nottingham GB United Kingdom (GB) Capella BioScience GB United Kingdom (GB)

How to cite

APA:

Ross, R., Corinaldesi, C., Migneco, G., El-Sherbiny, Y., Holmes, S., Distler, J.,... Del Galdo, F. (2019). BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Ross, Rebecca, et al. "BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2019.

BibTeX: Download